TABLE 1.
Characteristic | Low ANXA2 (n = 28) | High ANXA2 (n = 23) | p valuea |
---|---|---|---|
Age | 0.110 | ||
Years (mean ± S.D.) | 65 ± 13 | 59 ± 10 | |
Sex | 0.429 | ||
Male | 11 | 11 | |
Female | 17 | 12 | |
Histological type | 0.758 | ||
Adenocarcinoma | 22 | 16 | |
Squamous cell carcinoma | 5 | 6 | |
Large cell carcinoma | 1 | 1 | |
Stageb | 0.006 | ||
I | 20 | 6 | |
II | 1 | 5 | |
III | 6 | 7 | |
IV | 1 | 5 | |
Tumor status | 0.064 | ||
T1-2 | 26 | 17 | |
T3-4 | 2 | 6 | |
Lymph node status | 0.047 | ||
N0 | 22 | 12 | |
N1–N3 | 6 | 11 | |
Distal metastasis status | 0.045 | ||
M0 | 27 | 18 | |
M1 | 1 | 5 | |
Tumor differentiation | 0.539 | ||
Well | 9 | 5 | |
Moderate | 12 | 8 | |
Poor | 5 | 8 | |
Unknown | 2 | 2 | |
Recurrence status | 0.004 | ||
No | 22 | 9 | |
Yes | 6 | 14 |
a p value for age was derived from a two-tailed Student's t test; other p values were derived with a two-tailed Pearson's χ2 test.
b The tumor stage, tumor status, lymph node status, distal metastasis status, and tumor differentiation were classified according to the international system for staging lung cancer.